Literature DB >> 15128883

Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats.

Ichiro Hirahara1, Yumi Ogawa, Eiji Kusano, Yasushi Asano.   

Abstract

BACKGROUND: Sclerosing peritonitis (SP) and encapsulating peritoneal sclerosis (EPS) are serious complications of continuous ambulatory peritoneal dialysis. Although we have shown previously that matrix metalloproteinase-2 (MMP-2) is increased in peritoneal injury leading to SP/EPS, most of the MMP-2 in the dialysate drained from the peritoneal cavity was the latent form that was lacking activity. In the present study, we investigated whether MMP-2 causes peritoneal injury.
METHODS: To create an animal model of peritoneal injury, we administered intraperitoneally chlorhexidine gluconate to rats. Dialysate drained from these rats was analysed by gelatin zymography and MMP-2 activity was analysed by an in situ film zymography method. In vitro myofibroblasts were cultured in collagen three-dimensional culture and then MMP-2 in conditioned medium from the culture was analysed by gelatin zymography.
RESULTS: Zymographic analysis revealed that latent form MMP-2 levels were high in the dialysate from peritoneal injury rats, whereas the active form was barely detectable. MMP-2 activity in the peritoneal tissue of the peritoneal injury rats was strongly detected by in situ film zymography. In vitro myofibroblasts were promoted to produce MMP-2 and to activate MMP-2 in collagen three-dimensional culture.
CONCLUSIONS: In the present model, most of the MMP-2 was in the latent form, but activation of MMP-2 was promoted in the peritoneum during peritoneal injury. Activated MMP-2 may be associated with the progression of peritoneal injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128883     DOI: 10.1093/ndt/gfh262

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.

Authors:  Bülent Huddam; Murat Başaran; Gülay Koçak; Alper Azak; Funda Yalçın; Nihan Haberal Reyhan; Murat Duranay
Journal:  Int Urol Nephrol       Date:  2015-07-10       Impact factor: 2.370

Review 2.  A review of rodent models of peritoneal dialysis and its complications.

Authors:  Ji Wang; Shujun Liu; Hongyu Li; Jing Sun; Sijin Zhang; Xiaohong Xu; Yingying Liu; Yangwei Wang; Lining Miao
Journal:  Int Urol Nephrol       Date:  2014-11-26       Impact factor: 2.370

Review 3.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

4.  Matrix metalloproteinase-2 as a superior biomarker for peritoneal deterioration in peritoneal dialysis.

Authors:  Ichiro Hirahara; Eiji Kusano; Yoshiyuki Morishita; Makoto Inoue; Tetsu Akimoto; Osamu Saito; Shigeaki Muto; Daisuke Nagata
Journal:  World J Nephrol       Date:  2016-03-06

5.  Higher Dialysate Matrix Metalloproteinase-2 Levels Are Associated with Peritoneal Membrane Dysfunction.

Authors:  Yeoungjee Cho; David W Johnson; David A Vesey; Carmel M Hawley; Elaine M Pascoe; Margaret Clarke; Nicholas Topley
Journal:  Perit Dial Int       Date:  2014-10-07       Impact factor: 1.756

6.  Matrix metalloproteinase 9 is associated with peritoneal membrane solute transport and induces angiogenesis through β-catenin signaling.

Authors:  Manreet Padwal; Imad Siddique; Lili Wu; Katelynn Tang; Felix Boivin; Limin Liu; Jennifer Robertson; Darren Bridgewater; Judith West-Mays; Azim Gangji; Kenneth Scott Brimble; Peter J Margetts
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

7.  Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs).

Authors:  Yan Cai; Lei Zhu; Fan Zhang; Gang Niu; Seulki Lee; Shioko Kimura; Xiaoyuan Chen
Journal:  Mol Pharm       Date:  2013-05-08       Impact factor: 4.939

8.  Attenuation of methylglyoxal-induced peritoneal fibrosis: immunomodulation by interleukin-10.

Authors:  Akira Onishi; Tetsu Akimoto; Masashi Urabe; Ichiro Hirahara; Shigeaki Muto; Keiya Ozawa; Daisuke Nagata; Eiji Kusano
Journal:  Lab Invest       Date:  2015-09-14       Impact factor: 5.662

9.  A formalism for modelling traction forces and cell shape evolution during cell migration in various biomedical processes.

Authors:  Q Peng; F J Vermolen; D Weihs
Journal:  Biomech Model Mechanobiol       Date:  2021-04-23

10.  Elastic laminal invasion in colon cancer: diagnostic utility and histological features.

Authors:  Motohiro Kojima; Mitsuru Yokota; Norio Saito; Shogo Nomura; Atsushi Ochiai
Journal:  Front Oncol       Date:  2012-12-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.